{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:47:47Z","timestamp":1791229667191,"version":"4.1.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jaip.2024.03.021","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T23:22:05Z","timestamp":1715124125000},"page":"1095-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["How to Define and Manage Low-Risk Drug Allergy Labels"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9183-5032","authenticated-orcid":false,"given":"Ana Maria","family":"Copaescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.03.021_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaip.2018.06.010","article-title":"Drug-induced anaphylaxis documented in electronic health records","volume":"7","author":"Dhopeshwarkar","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.03.021_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jama.2017.6510","article-title":"Penicillin allergy is not necessarily forever","volume":"318","author":"Trubiano","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.03.021_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.anai.2021.05.009","article-title":"Association of beta-lactam allergy documentation and antibiotic use in patients with febrile neutropenia","volume":"127","author":"Naureckas Li","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The impact of a reported penicillin allergy on surgical site infection risk","volume":"66","author":"Blumenthal","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2024.03.021_bib6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2020.08.025","article-title":"Impact of reported NSAID \u201callergies\u201d on opioid use disorder in back pain","volume":"147","author":"Li","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib7","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jaip.2023.03.017","article-title":"Association of reported nonsteroidal anti-inflammatory drug (NSAID) adverse drug reactions with opioid prescribing after total joint arthroplasty","volume":"11","author":"Li","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.anai.2021.03.026","article-title":"Drug desensitization in the coronavirus disease 2019 pandemic era: local success to widespread potential","volume":"126","author":"Blumenthal","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib9","first-page":"29","article-title":"Potential negative effects of antimicrobial allergy labelling on patient care: a systematic review","volume":"71","author":"Wu","year":"2018","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.jaip.2024.03.021_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7812\/TPP\/08-073","article-title":"The falling rate of positive penicillin skin tests from 1995 to 2007","volume":"13","author":"Macy","year":"2009","journal-title":"Perm J"},{"key":"10.1016\/j.jaip.2024.03.021_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jaci.2020.04.058","article-title":"Accuracy of penicillin allergy diagnostic tests: a systematic review and meta-analysis","volume":"147","author":"Sousa-Pinto","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamainternmed.2023.2986","article-title":"Efficacy of a clinical decision rule to enable direct oral challenge in patients with low-risk penicillin allergy: the PALACE randomized clinical trial","volume":"183","author":"Copaescu","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2024.03.021_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.anai.2017.07.009","article-title":"Frequency of self-reported drug allergy: a systematic review and meta-analysis with meta-regression","volume":"119","author":"Sousa-Pinto","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00281-015-0540-2","article-title":"Adverse cutaneous drug eruptions: current understanding","volume":"38","author":"Hoetzenecker","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaip.2024.03.021_bib15","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","article-title":"Drug-induced cutaneous reactions. a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.03.021_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/all.12390","article-title":"Natural evolution of skin-test sensitivity in patients with IgE-mediated hypersensitivity to cephalosporins","volume":"69","author":"Romano","year":"2014","journal-title":"Allergy"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2024.03.021_bib17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0091-6749(99)70439-2","article-title":"Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics","volume":"103","author":"Blanca","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib18","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaip.2017.10.008","article-title":"Natural history of benign nonimmediate allergy to beta-lactams in children: a prospective study in retreated patients after a positive and a negative provocation test","volume":"6","author":"Tonson la Tour","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jaip.2020.08.047","article-title":"Differentiating between beta-lactam-induced serum sickness-like reactions and viral exanthem in children using a graded oral challenge","volume":"9","author":"Delli Colli","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib20","first-page":"259","article-title":"Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib22","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaip.2022.01.041","article-title":"Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and\/or multiple drug allergy labeled patients in a critical care setting","volume":"10","author":"Koo","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib23","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1164\/rccm.202001-0089LE","article-title":"Risk-stratified management to remove low-risk penicillin allergy labels in the ICU","volume":"201","author":"Stone","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.03.021_bib24","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-0471","article-title":"Allergy testing in children with low-risk penicillin allergy symptoms","volume":"140","author":"Vyles","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2024.03.021_bib25","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jaip.2019.04.006","article-title":"Risk-based pathway for outpatient penicillin allergy evaluations","volume":"7","author":"Blumenthal","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jaci.2017.02.005","article-title":"Tackling inpatient penicillin allergies: assessing tools for antimicrobial stewardship","volume":"140","author":"Blumenthal","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/1060028019826223","article-title":"Pharmacy-led \u03b2-lactam allergy interview (BLAI) reduces duration of fluoroquinolones within a community hospital","volume":"53","author":"Covington","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaip.2024.03.021_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.9820","article-title":"Evaluation of a pharmacist-led penicillin allergy assessment program and allergy delabeling in a tertiary care hospital","volume":"4","author":"Turner","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2024.03.021_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/QCO.0000000000000006","article-title":"Antimicrobial stewardship\u2019s new weapon? A review of antibiotic allergy and pathways to \u2018de-labeling\u2019","volume":"26","author":"Trubiano","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jaip.2024.03.021_bib30","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.jaip.2021.01.047","article-title":"Prevalence of antibiotic allergy labels in a tertiary referral center in Belgium","volume":"9","author":"Gilissen","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib31","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2020.2227","article-title":"Association Between penicillin allergy documentation and antibiotic use","volume":"180","author":"Blumenthal","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2024.03.021_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy306","article-title":"The safety and efficacy of an oral penicillin challenge program in cancer patients: a multicenter pilot study","volume":"5","author":"Trubiano","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaip.2024.03.021_bib33","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1016\/j.jaip.2021.06.057","article-title":"Establishing amoxicillin allergy in children through direct graded oral challenge (GOC): evaluating risk factors for positive challenges, safety, and risk of cross-reactivity to cephalosporines","volume":"9","author":"Exius","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2016.0033","article-title":"Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children","volume":"170","author":"Mill","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaip.2024.03.021_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1159\/000513974","article-title":"Evaluation of clinical properties and diagnostic test results of cephalosporin allergy in children","volume":"182","author":"Yilmaz Topal","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12008","article-title":"Frequency of severe reactions following penicillin drug provocation tests: a Bayesian meta-analysis","volume":"11","author":"Cardoso-Fernandes","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ajhp\/zxy043","article-title":"A\u00a0practical guide for pharmacists to successfully implement penicillin allergy skin testing","volume":"76","author":"Bland","year":"2019","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaip.2024.03.021_bib38","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaip.2017.08.006","article-title":"The cost of penicillin allergy evaluation","volume":"6","author":"Blumenthal","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jaip.2017.01.023","article-title":"Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits","volume":"5","author":"Tucker","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2500\/aap.2019.40.4184","article-title":"Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy","volume":"40","author":"Kuruvilla","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.03.021_bib41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jaip.2019.09.025","article-title":"Multicenter Australian study to determine criteria for low- and high-risk penicillin testing in outpatients","volume":"8","author":"Stevenson","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.anai.2019.08.005","article-title":"Safety of direct drug provocation testing in adults with penicillin allergy and association with health and economic benefits","volume":"123","author":"Li","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib43","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jaip.2019.05.037","article-title":"Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial","volume":"7","author":"Mustafa","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib44","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.jaip.2020.02.033","article-title":"Direct challenges to penicillin-based antibiotics in the inpatient setting","volume":"8","author":"Ramsey","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.03.021_bib46","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2024.03.021_bib47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jaip.2018.07.048","article-title":"Pathways to improved antibiotic allergy and antimicrobial stewardship practice: the validation of a beta-lactam antibiotic allergy assessment tool","volume":"7","author":"Devchand","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib48","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/jac\/dkz082","article-title":"Evaluation of a pharmacist-led penicillin allergy de-labelling ward-round: a novel antimicrobial stewardship intervention","volume":"74","author":"Devchand","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2024.03.021_bib49","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.jaip.2021.05.037","article-title":"Urticaria: the 1-1-1 criterion for optimized risk stratification in beta-lactam allergy delabeling","volume":"9","author":"Sabato","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib50","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.jaip.2021.05.046","article-title":"The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy","volume":"9","author":"Rose","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib51","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.16776","article-title":"Development and validation of a sulfa antibiotic allergy clinical decision rule","volume":"6","author":"Waldron","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2024.03.021_bib52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaip.2016.12.006","article-title":"Adverse and hypersensitivity reactions to prescription nonsteroidal anti-inflammatory agents in a large health care system","volume":"5","author":"Blumenthal","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib53","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaip.2021.11.006","article-title":"Safety, outcomes, and recommendations for two-step outpatient nonsteroidal anti-inflammatory drug challenges","volume":"10","author":"Li","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110101","article-title":"Incidence and risk factors of late adverse reactions to low-osmolar contrast media: a prospective observational study of 10,540 exposures","volume":"146","author":"Kang","year":"2022","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jaip.2024.03.021_bib55","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.jaip.2021.06.024","article-title":"One-dilution rapid desensitization protocol to chemotherapeutic and biological agents: a five-year experience","volume":"9","author":"Sala-Cunill","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib56","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jaip.2019.01.057","article-title":"Low cross-reactivity between cisplatin and other platinum salts","author":"Pasteur","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaip.2017.04.045","article-title":"Designing predictive models for beta-lactam allergy using the drug allergy and hypersensitivity database","volume":"6","author":"Chiriac","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib58","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jaip.2019.03.015","article-title":"Identifying low-risk beta-lactam allergy patients in a UK tertiary centre","volume":"7","author":"Siew","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib59","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1017\/ice.2019.50","article-title":"Outcomes from an inpatient beta-lactam allergy guideline across a large US health system","volume":"40","author":"Blumenthal","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jaip.2024.03.021_bib60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.anai.2015.05.011","article-title":"Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy","volume":"115","author":"Blumenthal","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib61","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/all.15169","article-title":"Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: a multicenter cohort study","volume":"77","author":"Trubiano","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anai.2019.04.009","article-title":"Acute care beta-lactam allergy pathways: approaches and outcomes","volume":"123","author":"Wolfson","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100093","article-title":"Beta-lactam antibiotic test doses in the emergency department","volume":"13","author":"Maguire","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.03.021_bib64","first-page":"147","article-title":"Improving antibiotic stewardship for inpatients with reported beta-lactam allergies and limited access to penicillin skin testing","volume":"48","author":"Berger","year":"2022","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"10.1016\/j.jaip.2024.03.021_bib65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.anai.2018.11.008","article-title":"Inpatient beta-lactam test-dose protocol and antimicrobial stewardship in patients with a history of penicillin allergy","volume":"122","author":"Sacco","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib66","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.amjmed.2021.12.012","article-title":"Expanding penicillin allergy evaluation in hospitalized patients","volume":"135","author":"DesBiens","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2024.03.021_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159406","article-title":"The impact of reporting a prior penicillin allergy on the treatment of methicillin-sensitive staphylococcus aureus bacteremia","volume":"11","author":"Blumenthal","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.03.021_bib68","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.jaip.2023.04.051","article-title":"Impact of an inpatient allergy guideline on beta-lactam and alternative antibiotic use","volume":"11","author":"Otani","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaip.2014.02.003","article-title":"Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers\u2019 antibiotic prescribing knowledge","volume":"2","author":"Blumenthal","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib70","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/all.14292","article-title":"Prevalence of self-reported and confirmed penicillin allergy in a Belgian outpatient population","volume":"75","author":"Van Gasse","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13223-020-00494-2","article-title":"Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology","volume":"16","author":"Jeimy","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib72","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaip.2017.02.019","article-title":"Addressing inpatient beta-lactam allergies: a multihospital implementation","volume":"5","author":"Blumenthal","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.anai.2021.07.005","article-title":"Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule","volume":"128","author":"Piotin","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib74","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1016\/j.jaip.2020.07.010","article-title":"Usefulness of an artificial neural network in the prediction of beta-lactam allergy","volume":"8","author":"Moreno","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib75","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/cid\/ciaa653","article-title":"The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study","volume":"73","author":"Chua","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2024.03.021_bib76","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.jaip.2019.02.046","article-title":"External validation of beta-lactam antibiotic allergy assessment tools: implications for clinical practice and workforce capacity","volume":"7","author":"Caughey","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jpc.15657","article-title":"ESCAPE-Allergy: evaluating screening for children and adolescents with penicillin allergy","volume":"58","author":"Rischin","year":"2022","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.jaip.2024.03.021_bib78","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/pharmacy9030127","article-title":"Effectiveness and feasibility of pharmacist-driven penicillin allergy de-labeling pilot program without skin testing or oral challenges","volume":"9","author":"Song","year":"2021","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.jaip.2024.03.021_bib79","first-page":"104","article-title":"Assessing use of a standardized allergy history questionnaire for patients with reported allergy to penicillin","volume":"74","author":"Manning","year":"2021","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.jaip.2024.03.021_bib80","doi-asserted-by":"crossref","first-page":"E394","DOI":"10.9778\/cmajo.20200077","article-title":"Amoxicillin oral provocation challenge in a primary care clinic: a descriptive analysis","volume":"9","author":"Gateman","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jaip.2024.03.021_bib82","author":"Clarke"},{"key":"10.1016\/j.jaip.2024.03.021_bib83","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.33703","article-title":"Validation of the PEN-FAST score in a pediatric population","volume":"5","author":"Copaescu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2024.03.021_bib84","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1093\/ofid\/ofab466.232","article-title":"Implementation of the PEN-FAST penicillin allergy screening tool in the emergency department during medical reconciliation","volume":"8","author":"Kaur","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaip.2024.03.021_bib85","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.jaip.2022.03.025","article-title":"Safety of direct oral challenge to amoxicillin in pregnant patients at a Canadian tertiary hospital","volume":"10","author":"Mak","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib86","article-title":"group ADs. Low self-reported penicillin allergy in South Africa-implications for global public health response","volume":"5","author":"Day","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jaip.2024.03.021_bib87","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/ACI.0000000000000758","article-title":"Role of clinical history in beta-lactam hypersensitivity","volume":"21","author":"Plager","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib88","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archinte.1992.00400150053009","article-title":"A\u00a0comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients","volume":"152","author":"Martin","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2024.03.021_bib89","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib90","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/pharmacy7030132","article-title":"Sulfonamide allergies","volume":"7","author":"Giles","year":"2019","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.jaip.2024.03.021_bib91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000443830","article-title":"Proven non-\u03b2-lactam antibiotic allergy in children","volume":"169","author":"Guvenir","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib92","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/pds.3937","article-title":"Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry","volume":"25","author":"Diphoorn","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2024.03.021_bib93","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamadermatol.2022.6378","article-title":"Worldwide prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"159","author":"Lee","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2024.03.021_bib94","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.jaip.2021.05.008","article-title":"Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System","volume":"9","author":"Bluestein","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib95","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jaip.2019.05.034","article-title":"Sulfonamide hypersensitivity: fact and fiction","volume":"7","author":"Khan","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib96","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000312632","article-title":"Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole","volume":"153","author":"Zawodniak","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib97","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib98","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaip.2019.07.003","article-title":"Oral challenge with trimethoprim-sulfamethoxazole in patients with \"Sulfa\" antibiotic allergy","volume":"8","author":"Krantz","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib99","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.anai.2021.04.001","article-title":"Outcome of trimethoprim-sulfamethoxazole challenge in previously reported patients with sulfa antibiotic allergy","volume":"127","author":"Benesch","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib100","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.anai.2023.07.024","article-title":"Drug allergy in older adults: a study from the United States Drug Allergy Registry","volume":"131","author":"Accarino","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2222.2010.03651.x","article-title":"Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response","volume":"41","author":"Dona","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib102","first-page":"80","article-title":"Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests","volume":"19","author":"Torres","year":"2009","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","article-title":"Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes","volume":"87","author":"Stevenson","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34668-1","article-title":"NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs","volume":"8","author":"Dona","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2024.03.021_bib105","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jdv.12658","article-title":"Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria","volume":"29","author":"Sanchez-Borges","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2024.03.021_bib106","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.jaip.2020.06.057","article-title":"Clinical control of CSU with antihistamines allows for tolerance of NSAID-exacerbated cutaneous disease","volume":"8","author":"Sanchez","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib107","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaip.2016.10.021","article-title":"Current knowledge and management of hypersensitivity to aspirin and NSAIDs","volume":"5","author":"Laidlaw","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib108","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11882-023-01064-3","article-title":"Recent updates in understanding NSAID hypersensitivity","volume":"23","author":"Minaldi","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.03.021_bib109","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/all.12855","article-title":"Immediate hypersensitivity reactions to ibuprofen and other arylpropionic acid derivatives","volume":"71","author":"Blanca-Lopez","year":"2016","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.jaip.2024.03.021_bib110","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jaip.2023.03.036","article-title":"Evaluation and updated classification of acute hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs): NSAID-exacerbated or -induced food allergy","volume":"11","author":"Romano","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib111","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2222.2010.03648.x","article-title":"Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity","volume":"41","author":"Viola","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib112","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11882-015-0593-2","article-title":"Rapid aspirin challenge in patients with aspirin allergy and acute coronary syndromes","volume":"16","author":"Cook","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.03.021_bib114","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1398-9995.2011.02684.x","article-title":"Response to a selective COX-2 inhibitor in patients with urticaria\/angioedema induced by nonsteroidal anti-inflammatory drugs","volume":"66","author":"Do\u00f1a","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2500\/aap.2016.37.3917","article-title":"The value of the clinical history for the diagnosis of immediate nonsteroidal anti-inflammatory drug hypersensitivity and safe alternative drugs in children","volume":"37","author":"Topal","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.03.021_bib116","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000335631","article-title":"Immediate and delayed cutaneous reactions to radiocontrast media","volume":"97","author":"Brockow","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib117","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/j.jaip.2019.04.042","article-title":"Cross-reactivity and tolerability of celecoxib in adult patients with NSAID hypersensitivity","volume":"7","author":"Li","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib118","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/all.14656","article-title":"Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity","volume":"76","author":"Torres","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib119","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160729","article-title":"Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors","volume":"90","author":"Li","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jaip.2024.03.021_bib120","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinimag.2015.04.014","article-title":"Adverse reactions to intravenous contrast media: an unexpected discrepancy between inpatient and outpatient cohorts","volume":"39","author":"Dean","year":"2015","journal-title":"Clin Imaging"},{"key":"10.1016\/j.jaip.2024.03.021_bib121","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2214\/AJR.07.3421","article-title":"Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions","volume":"191","author":"Wang","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"Suppl","key":"10.1016\/j.jaip.2024.03.021_bib122","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00004424-198011001-00011","article-title":"Administration of radiographic contrast media in high-risk patients","volume":"15","author":"Greenberger","year":"1980","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jaip.2024.03.021_bib123","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib124","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.2019190485","article-title":"Hypersensitivity reactions to iodinated contrast media: a multicenter study of 196 081 patients","volume":"293","author":"Cha","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2024.03.021_bib125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eclinm.2018.07.002","article-title":"Immediate hypersensitivity to contrast agents: the French 5-year CIRTACI Study","volume":"1","author":"Clement","year":"2018","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaip.2024.03.021_bib127","article-title":"Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.03.021_bib128","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.anai.2017.08.014","article-title":"Immediate reactions to iodinated contrast media","volume":"119","author":"Morales-Cabeza","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib129","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jaip.2019.04.005","article-title":"Radiocontrast media hypersensitivity: skin testing differentiates allergy from nonallergic reactions and identifies a safe alternative as proven by intravenous provocation","volume":"7","author":"Trautmann","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/all.12589","article-title":"Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis","volume":"70","author":"Yoon","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.03.021_bib131","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaci.2015.07.035","article-title":"Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions","volume":"137","author":"Lerondeau","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib132","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaip.2019.08.001","article-title":"Validation of the prescreening intradermal skin test for predicting hypersensitivity to iodinated contrast media: a prospective study with ICM challenge","volume":"8","author":"Lee","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib133","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.jaip.2021.02.060","article-title":"DRESS and AGEP reactions to iodinated contrast media: a French case series","volume":"9","author":"Soria","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib134","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00262-012-1273-x","article-title":"Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization","volume":"61","author":"Castells","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaip.2024.03.021_bib135","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/ijms18061316","article-title":"Drug hypersensitivity and desensitizations: mechanisms and new approaches","volume":"18","author":"de Las Vecillas S\u00e1nchez","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2024.03.021_bib136","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jaip.2019.12.032","article-title":"Allergy evaluation of hypersensitivity to platinum salts and taxanes: a six-year experience","volume":"8","author":"Pradelli","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib137","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12016-022-08932-2","article-title":"Premedication protocols to prevent hypersensitivity reactions to chemotherapy: a literature review","volume":"62","author":"ALMuhizi","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib138","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jnci\/90.4.300","article-title":"Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in\u00a0vitro study","volume":"90","author":"Szebeni","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaip.2024.03.021_bib139","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41419-022-04964-w","article-title":"Paclitaxel binds and activates C5aR1: a new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions","volume":"13","author":"Brandolini","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jaip.2024.03.021_bib140","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2024.03.021_bib141","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaip.2014.04.010","article-title":"Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review","volume":"2","author":"Banerji","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib142","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"1","author":"Ring","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.03.021_bib143","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib144","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) v5.0","year":"2017"},{"key":"10.1016\/j.jaip.2024.03.021_bib145","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.iac.2017.06.003","article-title":"Platinum chemotherapy hypersensitivity: prevalence and management","volume":"37","author":"Otani","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.03.021_bib146","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2009.02.042","article-title":"Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management","volume":"123","author":"Hesterberg","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib147","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.anai.2015.07.017","article-title":"Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy","volume":"115","author":"Wang","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib148","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaip.2019.08.055","article-title":"Platin risk stratification algorithm with modified intradermal skin test protocol","volume":"8","author":"Levin","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib149","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1016\/j.jaip.2021.08.010","article-title":"One-bag desensitization protocols in the management of chemotherapy hypersensitivity","volume":"9","author":"Tsao","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.18176\/jiaci.0552","article-title":"Pilot Experience using drug provocation testing for the study of hypersensitivity to chemotherapy and biological agents","volume":"31","author":"Mart\u00ed-Garrido","year":"2021","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib151","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jaip.2018.07.031","article-title":"A\u00a0large single-hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents","volume":"7","author":"Madrigal-Burgaleta","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib152","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jaip.2018.12.010","article-title":"Platin chemotherapy hypersensitivity reactions: expanding the scope of practice and improving care","volume":"7","author":"Levin","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib153","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2015.10.039","article-title":"Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions","volume":"137","author":"Picard","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.03.021_bib154","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.jaip.2020.08.005","article-title":"Controversies in allergy: chemotherapy reactions, desensitize, or delabel?","volume":"8","author":"Hong","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib155","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1016\/j.jaip.2022.08.020","article-title":"Allergy electronic health record documentation: a 2022 work group report of the AAAAI adverse reactions to drugs, biologicals, and latex committee","volume":"10","author":"Guyer","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib156","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.jaip.2020.07.013","article-title":"Implementation and assessment of an anaphylaxis simulation curriculum for Boston-area allergy and immunology trainees","volume":"8","author":"Barmettler","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.03.021_bib157","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13223-023-00764-9","article-title":"Simulation-based education to improve management of refractory anaphylaxis in an allergy clinic","volume":"19","author":"Copaescu","year":"2023","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824002836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824002836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T06:11:53Z","timestamp":1724479913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824002836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":155,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2213219824002836"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.03.021","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to Define and Manage Low-Risk Drug Allergy Labels","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}